Tech Company Financing Transactions

Neurocrine Biosciences Funding Round

Neurocrine Biosciences closed a $10 million funding round on 12/17/2009. Investors included Venrock.

Transaction Overview

Announced On
12/17/2009
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
12780 El Camino Real
San Diego, CA 92130
USA
Email Address
Overview
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) of San Diego is a product based biopharmaceutical company focusing on the development and commercialization of innovative pharmaceutical products to treat unmet medical needs.
Profile
Neurocrine Biosciences LinkedIn Company Profile
Social Media
Neurocrine Biosciences Company Twitter Account
Company News
Neurocrine Biosciences News
Facebook
Neurocrine Biosciences on Facebook
YouTube
Neurocrine Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Gorman
  Kevin Gorman LinkedIn Profile  Kevin Gorman Twitter Account  Kevin Gorman News  Kevin Gorman on Facebook
Chief Financial Officer
Matthew Abernethy
  Matthew Abernethy LinkedIn Profile  Matthew Abernethy Twitter Account  Matthew Abernethy News  Matthew Abernethy on Facebook
Chief Medical Officer
Eiry Roberts
  Eiry Roberts LinkedIn Profile  Eiry Roberts Twitter Account  Eiry Roberts News  Eiry Roberts on Facebook
VP - Bus. Development
Haig Bozigian
  Haig Bozigian LinkedIn Profile  Haig Bozigian Twitter Account  Haig Bozigian News  Haig Bozigian on Facebook
VP - Bus. Development
Kyle Gano
  Kyle Gano LinkedIn Profile  Kyle Gano Twitter Account  Kyle Gano News  Kyle Gano on Facebook
VP - General Counsel
Darin Lippoldt
  Darin Lippoldt LinkedIn Profile  Darin Lippoldt Twitter Account  Darin Lippoldt News  Darin Lippoldt on Facebook
VP - Human Resources
Julie Cooke
  Julie Cooke LinkedIn Profile  Julie Cooke Twitter Account  Julie Cooke News  Julie Cooke on Facebook
VP - R & D
Dimitri Grigoriadis
  Dimitri Grigoriadis LinkedIn Profile  Dimitri Grigoriadis Twitter Account  Dimitri Grigoriadis News  Dimitri Grigoriadis on Facebook
VP - Regulatory Affairs
Malcolm Lloyd-Smith
  Malcolm Lloyd-Smith LinkedIn Profile  Malcolm Lloyd-Smith Twitter Account  Malcolm Lloyd-Smith News  Malcolm Lloyd-Smith on Facebook


 

 

Browse more venture capital transactions:

Prev: 12/17/2009: Inertia Beverage Group venture capital transaction
Next: 12/17/2009: RepairPal venture capital transaction

 

Share this article

 


News on VC Transactions

We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary